Rudra Shares and Stock Brokers LTD.
ABOUT US | CONTACT US| CAREER
BACKOFFICE LOGIN
INDIA INX Global
  ONLINE TRADING
search
Equity

COMPANY SNAPSHOT

Aarti Pharmalabs LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:543748
ISIN Demat:INE0LRU01027
Book Value(Rs):178.9180656
NSE Symbol:AARTIPHARM
Div & Yield %:0.49
Market Cap (Rs Cr.):5495.56
P/E(TTM):27.39
EPS(TTM):22.14
Face Value(Rs):5
  Change Company 
Stock Price Details
Last Price (Rs) 605.00 
Change (Rs) -1.40 (-0.23%) 
Best Buy (Rs) 605.3(x58) 
Best Sell(Rs) 606.45(x36) 
Today's Range 601.50 - 611.55 
52-Week Range (Rs) 321.00 - 624.20 
Beta (1 Year) 0.91 
Chart
| | | |
Index Details
BSE HC, BSE SmallCap
Corporate Announcements
Board of Aarti Pharmalabs recommends Final Dividend
Aarti Pharmalabs to discuss results
Board of Aarti Pharmalabs recommends interim divide...
Board of Aarti Pharmalabs recommends interim divide...
Aarti Pharmalabs announces board meeting date
Aarti Pharmalabs to convene board meeting
Aarti Pharmalabs to hold AGM
Aarti Pharmalabs to declare Quarterly Result
Aarti Pharmalabs to discuss results
Aarti Pharmalabs receives ratings for LT bank facili...
Corporate Details
Incorporation Year :  2019
Chairman : Rashesh C Gogri
Ownership Group : Indian Private
Sector : MAN
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
Registered Office
Aarti Pharmalabs Ltd
Plot No 22/C/1 & 22/C/2,
1st Phase GIDC Vapi,
Valsad,
Gujarat-396195
Phone : 91-22-6797 6666
Fax : 91-22-2565 3234
E-Mail : co.apl@aartipharmalabs.com ; investorrelations@aar
URL : https://www.aartipharmalabs.com
Investor Returns
  Date Price (Rs) Returns (%)
1Week 09-May-2024 495.15 22.47
1Month 16-Apr-2024 468.90 29.32
3Month 16-Feb-2024 536.20 13.09
6Month 16-Nov-2023 400.40 51.45
1Year 16-May-2023 367.00 65.23
Mutual Funds Holding
Scheme Name % Holding Market Value(Rs)
Aditya Birla SL Flexi Cap Fund 0.22 44.93
ICICI Pru P.H.D Fund 0.80 30.75
HDFC Multi Cap Fund 0.16 22.00
Quant Business Cycle Fund 1.39 17.19
Quant Healthcare Fund 2.95 8.25
Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln
Company Last Price(Rs) Change(%) 52Week High(Rs) 52Week Low(Rs) Market Cap(Rs)
Sun Pharmaceuticals Industries Ltd 1,529.15 -0.46 1,638.70 922.55 368,597.83
Cipla Ltd 1,406.60 -0.95 1,519.00 911.80 114,654.12
Zydus Lifesciences Ltd 1,037.35 +2.84 1,033.15 482.55 101,498.82
Dr Reddys Laboratories Ltd 5,810.30 -0.52 6,505.50 4,383.40 97,429.37
Mankind Pharma Ltd 2,126.45 +1.64 2,488.65 1,240.75 83,816.88
ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers / email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile / email at the end of the day .... Issued in the interest of Investors.    ||     Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.   ||    KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Attention Investors

1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020

2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on
your email id and/or mobile number to create pledge.

3. Pay 20% upfront margin of the transaction value to trade in cash market segment.

4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191
dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

(Issued in the interest of Investors.)

Important Message

This is to inform that, many instances were reported by general public where fraudsters are cheating general public by misusing our brand name RUDRA SHARES.
The fraudsters are luring the general public to transfer them money by falsely committing attractive brokerage / investment schemes of share market and/or Mutual Funds
and/or personal loan facilities. Though as for as possible, we initiate legal actions against the fraudsters, we request you to not fall prey to such fraudsters. You can check
about our products and services by visiting our website www.rudrashares.com. You can also write to us at compliance@rudrashares.com, to know more about products and services.

SEBI REGN. (STOCK BROKER) - NSE-CM/FO/CD / BSE-CM/FO/CD / MCX / NCDEX - INZ000004937
SEBI REGN. (DP)IN-DP-558-2021
@ 2015. ALL RIGHTS RESERVED. RUDRA SHARES & STOCK BROKERS LTD.
Designed, developed and powered by C-MOTS Infotech (ISO 9001:2015 certified)